OSCR Stock Analysis: Buy, Sell, or Hold?
OSCR - Oscar Health, Inc.
$31.81
-0.23 (-0.72%)
▼
5d:
+0.82%
30d:
+12.84%
90d:
+40.5%
WAIT
LOW Confidence
Analysis Updated: Aug 24, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When OSCR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: OSCR shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: OSCR shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$36.32
Based on 5.8% avg growth
INTRINSIC VALUE TODAY
$22.55
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: OSCR is currently trading at $31.81, which is considered extended relative to its 30-day fair value range of $28.52 to $31.67. From a valuation perspective, the stock is trading at a premium (Forward PE: 17.0) compared to its historical average (14.6). At these levels, the market is pricing in 5.2% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, OSCR is in a strong uptrend. Immediate support is located at $27.09, while resistance sits at $33.55.
Market Sentiment: OSCR scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, OSCR is in a strong uptrend. Immediate support is located at $27.09, while resistance sits at $33.55.
Market Sentiment: OSCR scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$28.52 -
$31.67
Company Quality Score
37/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
21.4%
Protect Your Profits
Holding OSCR? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (5/100)
- BULLISH: High volume confirmation
- BEARISH: Trading above Wall St target ($30.40)
- NEUTRAL: PE elevated vs history but 5.2% growth expectation is conservative given 126% recent growth
- WARNING: Composite score 37/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$28.52 -
$31.67
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$27.09
Resistance Level
$33.55
Current Trend
Strong Uptrend
Technical data as of
Aug 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
17.03
Wall Street Target
$30.40
(-5.1%)
Revenue Growth (YoY)
70.4%
Earnings Growth (YoY)
125.6%
Profit Margin
3.6%
Valuation Premium vs History
+5.2% premium
PE vs Historical
17.0 vs 14.6
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.2%
(market-implied from PE analysis)
1-Year Target
$33.71
(+5%)
2-Year Target
$35.46
(+11%)
3-Year Target
$37.30
(+16%)
3-Yr Target (if PE normalizes)
(PE: 17→15)
PE COMPRESSION
$31.99
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: 7.5%)
$46.92
(+46%)
Base:
(SPY PE: 17.0, Growth: 7.5%)
$39.80
(+24%)
Bear:
(PE: 14.5, Growth: 7.5%)
$33.83
(+6%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (25x PE), but valuation improves significantly next year (17x PE) as earnings recover.
Trailing PE: 24.86 | Current EPS (TTM): $1.27
Bull Case
$51.46
(+62%)
Analyst growth 48.2%, PE expands to 27.3
Base Case
$46.78
(+47%)
Market implied 48.2%, PE stable at 24.9
Bear Case
$21.47
(-33%)
Severe decline -20.0%, PE contracts to 21.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 24, 2026 9:47 PM ET
Data refreshes hourly during market hours. Next update: 10:47 PM
Data refreshes hourly during market hours. Next update: 10:47 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OSCR showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Mark T Bertolini
BUY
1000000 shares
2026-04-06
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
28 analysts |
$116 | 59 HOLD |
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
27 analysts |
$475 | 61 BUY |
|
CI
Cigna Corp |
STRONG BUY
25 analysts |
$341 | 58 HOLD |
|
ELV
Elevance Health Inc |
STRONG BUY
22 analysts |
$449 | 57 HOLD |
|
HUM
Humana Inc |
HOLD
26 analysts |
$416 | 60 BUY |
Advanced OSCR Option Strategies
Professional options setups generated by AI based on today's OSCR price and gamma walls.
